GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Return-on-Tangible-Asset

Utah Medical Products (Utah Medical Products) Return-on-Tangible-Asset : 14.97% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Utah Medical Products's annualized Net Income for the quarter that ended in Dec. 2023 was $17.14 Mil. Utah Medical Products's average total tangible assets for the quarter that ended in Dec. 2023 was $114.51 Mil. Therefore, Utah Medical Products's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 14.97%.

The historical rank and industry rank for Utah Medical Products's Return-on-Tangible-Asset or its related term are showing as below:

UTMD' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 14.59   Med: 20.16   Max: 32.27
Current: 14.59

During the past 13 years, Utah Medical Products's highest Return-on-Tangible-Asset was 32.27%. The lowest was 14.59%. And the median was 20.16%.

UTMD's Return-on-Tangible-Asset is ranked better than
93.39% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: -2.43 vs UTMD: 14.59

Utah Medical Products Return-on-Tangible-Asset Historical Data

The historical data trend for Utah Medical Products's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Return-on-Tangible-Asset Chart

Utah Medical Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.52 15.51 18.79 17.91 15.33

Utah Medical Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.41 15.65 14.21 14.97 13.51

Competitive Comparison of Utah Medical Products's Return-on-Tangible-Asset

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Return-on-Tangible-Asset falls into.



Utah Medical Products Return-on-Tangible-Asset Calculation

Utah Medical Products's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=16.635/( (100.143+116.82)/ 2 )
=16.635/108.4815
=15.33 %

Utah Medical Products's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=17.144/( (112.193+116.82)/ 2 )
=17.144/114.5065
=14.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data.


Utah Medical Products  (NAS:UTMD) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Utah Medical Products Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Utah Medical Products (Utah Medical Products) Business Description

Traded in Other Exchanges
Address
7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Executives
Paul O Richins director, officer: VP, Treasurer, Asst. Secretary 7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne director
Ernst G Hoyer director
Kevin L Cornwell director, officer: Chairman, CEO, Secretary
Brian Koopman officer: Principal Financial Officer 108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson director 7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire officer: Chief Financial Officer 5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett director